Autres langues Allergy Therapeutics plc

Actions

AGY

GB00B02LCQ05

Marché Fermé - London S.E. Autres places de cotation 17:35:04 08/05/2024			Varia. 5j.	Varia. 1 janv.
3,3 ^GBX	+5,77 %		+13,79 %	+32,00 %

07/05	Abingdon Health achète IVDeology Holdings	AN
07/05	Allergy Therapeutics plc apporte des précisions sur les résultats positifs de l'étude de terrain de phase III G306 visant à évaluer l'efficacité et l'innocuité du Grass MATA MPL	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Abingdon Health buys IVDeology Holdings	07/05
Allergy Therapeutics plc Provides Further Details from Positive Top Line Results from G306 Phase III Field Study G306 to Evaluate the Efficacy and Safety of Grass MATA MPL	07/05
Allergy Therapeutics Announces Resignation of Mary Tavener as Non-Executive Director	03/04
EARNINGS AND TRADING: Solid State ups outlook; Quartix trading in line	27/03
Allergy Therapeutics Gets OK to Draw Down GBP15 Million From Amended Loan Facility	27/03
AIM WINNERS & LOSERS: Norman Broadbent profit swing on rising revenue	27/03
Earnings Flash (AGY.L) ALLERGY THERAPEUTICS Reports Fiscal H1 Revenue GBP33.6M	27/03
Earnings Flash (AGY.L) ALLERGY THERAPEUTICS Posts Fiscal H1 Loss GBX-0.58	27/03
Allergy Therapeutics plc Provides Sales Guidance for the Second Half and Full Year Ending on 30 June 2024	27/03
Allergy Therapeutics plc Reports Earnings Results for the Half Year Ended December 31, 2023	27/03
Allergy Therapeutics starts dosing patients in peanut allergy trial	12/03
Allergy Therapeutics Announces Commencement of Subcutaneous Dosing of Peanut Allergic Patients in the Phase I/IIa PROTECT Trial Evaluating its Novel Virus-Like Particle Based Peanut Allergy Vaccine Candidate	12/03
Allergy Therapeutics plc Announces Appointment of Shaun Furlong to Board of Directors	11/03
Allergy Therapeutics forecasts revenue drop but trials going well	14/02
Alliance Pharma appoints chair; FireAngel sales down	05/02
Scancell's Chief Development Officer to Step Down	05/02
Allergy Therapeutics plc - Publication of Annual Report and Accounts 2023	31/01
Allergy Therapeutics resumes trading on AIM; annual revenue plunges	30/01
Allergy Therapeutics amends facility, plans warrant issue	27/12
Allergy Therapeutics Agrees Amendment to Loan Facility	27/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Allergy Therapeutics plc

Actions

AGY

GB00B02LCQ05

Autres langues

Filtres